1. Home
  2. GPK vs IMNM Comparison

GPK vs IMNM Comparison

Compare GPK & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graphic Packaging Holding Company

GPK

Graphic Packaging Holding Company

N/A

Current Price

$9.39

Market Cap

3.1B

ML Signal

N/A

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$24.97

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPK
IMNM
Founded
2007
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.5B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
GPK
IMNM
Price
$9.39
$24.97
Analyst Decision
Hold
Strong Buy
Analyst Count
9
10
Target Price
$13.08
$32.80
AVG Volume (30 Days)
3.9M
951.9K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
4.58%
N/A
EPS Growth
N/A
51.40
EPS
N/A
N/A
Revenue
$8,617,000,000.00
$6,941,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.15
$1,127.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.79
$8.93
52 Week High
$21.24
$30.06

Technical Indicators

Market Signals
Indicator
GPK
IMNM
Relative Strength Index (RSI) 27.61 42.00
Support Level $9.09 $19.28
Resistance Level $10.02 $27.14
Average True Range (ATR) 0.41 1.08
MACD -0.24 -0.48
Stochastic Oscillator 1.24 1.54

Price Performance

Historical Comparison
GPK
IMNM

About GPK Graphic Packaging Holding Company

Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Americas Paperboard Packaging, and International Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company operates in Americas, Europe and Asia Pacific regions.

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: